ArticleDiscover oncology2025
Advancing understanding of autoimmune diseases and lung cancer: trends, themes, and future directions.
Article in Discover oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeAutoimmune diseases are closely linked with lung cancer (LC), forming a complex bidirectional relationship that poses significant challenges to treatment. A bibliometric analysis was conducted to investigate global research trends, key hotspots, and potential future directions in this field.
methodsThis study utilized bibliometric methods, analyzing 1161 publications from the Web of Science database spanning the years 1980 to 2024. Visualization and analysis were performed using tools such as VOSviewer, CiteSpace, and the bibliometrix R package.
resultsThe dataset encompassed research from 73 countries, 1860 organizations, and 6734 authors, published in 541 sources. The United States emerged as the leading contributor in terms of publication output, with the Mayo Clinic identified as the most productive institution. The Cureus Journal of Medical Science published the highest number of articles, whereas Chest garnered the most citations. Among individual researchers, Sasha Bernatsky stood out as the most prolific and frequently co-cited author. Keyword analysis revealed significant focus areas, including immune therapy-related adverse events, interstitial lung disease, comorbidities, diagnostic methods, and autoantibodies in paraneoplastic syndromes. Emerging research priorities center on understanding immune mechanisms, addressing comorbidities, and advancing diagnostic approaches.
conclusionThis bibliometric study provides a comprehensive overview of research trends and gaps in the intersection of autoimmune diseases and LC. It highlights the importance of exploring immune therapy mechanisms, managing comorbidities, and optimizing diagnostic strategies as key areas for future investigation.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.